Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)
- Status
- UNKNOWN
- Phase
- PHASE2
Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
- Status
- RECRUITING
- Phase
- PHASE3
Registry Platform Gastric/Esophageal Cancer (SAPHIR)
- Status
- RECRUITING
- Phase
- N/A
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
- Status
- UNKNOWN
- Phase
- PHASE1
Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Reconstruction
- Status
- UNKNOWN
- Phase
- NA
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction
- Status
- UNKNOWN
- Phase
- NA
The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy
- Status
- COMPLETED
- Phase
- N/A
Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2